|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,400.00 JPY | -1.22% |
|
-6.75% | -14.77% |
| 05-13 | REGENXBIO Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS II | CI |
| 05-09 | Jefferies Adjusts Nippon Shinyaku's Price Target to 3,500 Yen From 3,800 Yen, Keeps at Hold | MT |
| Capitalization | 229B 1.57B 1.36B 1.28B 1.17B 2.16B 136B 2.43B 15.2B 5.82B 62.32B 5.89B 5.77B | P/E ratio 2025 |
7.87x | P/E ratio 2026 * | 9.35x |
|---|---|---|---|---|---|
| Enterprise value | 161B 1.1B 955M 899M 817M 1.51B 95.31B 1.7B 10.65B 4.07B 43.66B 4.13B 4.04B | EV / Sales 2025 |
1.27x | EV / Sales 2026 * | 0.97x |
| Free-Float |
90.75% | Yield 2025 |
3.26% | Yield 2026 * | 3.76% |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
More news
| 1 day | -1.22% | ||
| 1 week | -6.75% | ||
| Current month | -4.52% | ||
| 1 month | -0.44% | ||
| 3 months | -15.74% | ||
| 6 months | -18.72% | ||
| Current year | -14.77% |
| 1 week | 3,391 |  | 3,644 |
| 1 month | 3,391 | | 3,751 |
| Current year | 3,267 | | 4,182 |
| 1 year | 2,875 | | 4,414 |
| 3 years | 2,694 | | 8,880 |
| 5 years | 2,694 | | 9,840 |
| 10 years | 2,694 | | 10,360 |
| Manager | Title | Age | Since |
|---|---|---|---|
Toru Nakai
PSD | President | 53 | 2021-05-31 |
Hideyuki Fujii
DFI | Director of Finance/CFO | - | - |
| Chief Tech/Sci/R&D Officer | 63 | 2021-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 2021-05-31 | |
Shouzou Sano
BRD | Director/Board Member | 64 | 2015-05-31 |
Takashi Takaya
BRD | Director/Board Member | 64 | 2018-05-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.88% | 28 M€ | -7.66% | - | |
| 0.23% | 60 M€ | -0.50% | - | |
| 0.23% | 4 M€ | -30.99% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.22% | -6.75% | +8.59% | -54.67% | 1.57B | ||
| -2.84% | -6.91% | -13.71% | +156.52% | 685B | ||
| -0.62% | -4.65% | +0.70% | -13.42% | 360B | ||
| -0.10% | -3.02% | +8.75% | +29.16% | 327B | ||
| -2.58% | -7.83% | -51.84% | +25.00% | 326B | ||
| -0.27% | -3.86% | +2.57% | -13.95% | 255B | ||
| -0.34% | -2.34% | +0.96% | +20.36% | 228B | ||
| -1.52% | -5.41% | -16.68% | +2.61% | 217B | ||
| -0.29% | -3.24% | -39.52% | -10.19% | 199B | ||
| -0.10% | -2.00% | -6.11% | +21.36% | 156B | ||
| Average | -0.99% | -4.43% | -10.63% | +16.28% | 275.36B | |
| Weighted average by Cap. | -1.31% | -4.71% | -12.61% | +44.63% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 160B 1.1B 950M 895M 813M 1.5B 94.89B 1.7B 10.6B 4.06B 43.47B 4.11B 4.02B | 169B 1.16B 1B 946M 859M 1.59B 100B 1.79B 11.2B 4.29B 45.92B 4.34B 4.25B |
| Net income | 31.08B 213M 185M 174M 158M 293M 18.46B 330M 2.06B 789M 8.46B 800M 783M | 24.52B 168M 146M 137M 125M 231M 14.56B 260M 1.63B 622M 6.67B 631M 617M |
| Net Debt | -68.58B -470M -408M -384M -349M -646M -40.72B -728M -4.55B -1.74B -18.66B -1.76B -1.73B | -65.13B -447M -387M -365M -332M -613M -38.68B -691M -4.32B -1.65B -17.72B -1.68B -1.64B |
More financial data
* Estimated data
Employees
2,213
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-20 | 3,400.00 ¥ | -1.22% | 241,400 |
| 25-06-19 | 3,442.00 ¥ | -2.08% | 156,600 |
| 25-06-18 | 3,515.00 ¥ | -0.23% | 113,900 |
| 25-06-17 | 3,523.00 ¥ | -1.23% | 116,100 |
| 25-06-16 | 3,567.00 ¥ | -2.17% | 167,000 |
Delayed Quote Japan Exchange, June 20, 2025 at 02:30 am
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
3,400.00JPY
Average target price
4,281.25JPY
Spread / Average Target
+25.92%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4516 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition